Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation

Gut

Volumn 44, Issue 5, 1999, Pages 754-758

  Goulis, J ^a   Chau, T N ^a   Jordan, S ^a   Mehta, A B ^a   Watkinson, A ^a   Rolles, K ^a   Burroughs, A K ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Cirrhosis; Orthotopic liver transplantation; Platelets; Thrombocytopenia; Thrombopoietin

Indexed keywords

THROMBOPOIETIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTHROMBIN TIME; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

EID: 0033042073     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.44.5.754     Document Type: Article

References (27)

1. 1 Aster R. Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenicthrombocytopenia. J Clin Invest 1966;45:645-57.
2. 2 Harker LA, Finch CA. Thrombokinetics in man. J Clin Invest 1969;48:963-74.
3. 3 Stein S, Harker LA. Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis. J Lab Clin Med 1982;99:217-30.
4. 4 Mutchnick MG, Lerner E, Conn HO. Effect of portacaval anastomosis on hypersplenism. Dig Dis Sci 1980;25:929-38.
5. 5 Soper NJ, Rikkers LF. Effect of operations for variceal hemorrhage on hypersplenism. Am J Surg 1982;144:700-3.
6. 6 Sanyal AJ, Freedman AM, Purdum PP, et al. The hematologic consequences of transjugular intrahepatic portosystemic shunts. Hepatology 1996;23:32-9.
7. 7 Alvarez OA, Lopera GA, Patel V, et al. Improvement of thrombocytopenia due to hypertension after transjugular intrahepatic portosystemic shunt placement in cirrhotic patients. Am J Gastroenterol 1996;91:134-7.
8. 8 Yamaga K, Tzakis AG, Shimada M, et al. Reversal of hypersplenism following orthotopic liver transplantation. Ann Surg 1989;210:180-3.
9. 9 de Sauvage FJ, Hass PE, Spencer SD, et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 1994;369:533-8.
10. 10 Lok S, Kaushansky K, Holly RD, et al. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 1994;369:565-8.
11. 11 Nichol JL, Hokom MM, Horncohl A, et al. Megakaryocyte growth and development factor: analysis of in vitro effects on human megakaryocytopoiesis and endogenous serum levels during chemotherapy induced thrombocytopenia. J Clin Invest 1995;95:2973-8.
12. 12 Shimada Y, Kato T, Ogami K, et al. Production of thrombopoietin (TPO) by rat hepatocytes and hepatoma cell lines. Exp Hematol 1995;23:1388-96.
13. 13 Shimodaira S, Ishida F, Ichikawa N, et al. Serum thrombopoietin (c-Mpl ligand) levels in patients with liver cirrhosis. Thromb Haemost 1996;76:545-8.
14. 14 Akriviadis EA, Cohen SM, Chen DCP, et al. Thrombopoietin (TPO) levels are increased in patients with cirrhosis and do not appear to play a role in the pathogenesis of thrombocytopenia of cirrhosis [abstract]. Hepatology 1997; 26:184A.
15. 15 Satoi J, Sanjyou Y, Takekuma A, et al. Serum thrombopoietin and hepatosplenomegaly in patients with chronic liver disease [abstract]. Hepatology 1997;26:206A.
16. 16 Peck-Radosavljevic M, Zacherl J, Meng GY, et al. Is inadequate thrombopoietin production a major cause of thrombocytopenia in cirrhosis of the liver? J Hepatol 1997; 27:127-31.
17. 17 Martin TG, Somberg KA, Meng GY, et al. Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation. Ann Intern Med 1997;127:285-8.
18. 18 Siemensma NP, Bathal PS, Penington DG. The effect of massive liver resection on platelet kinetics in the rat. J Lab Clin Med 1975;86:817.
19. 19 Sezai S, Kamisaka K, Ikegami F, et al. Regulation of hepatic thrombopoietin production by portal hemodynamics in liver cirrhosis. Am J Gastroenterol 1998;93:80-2.
20. 20 Plevak DJ, Halma GA, Forstrom LA, et al. Thrombocytopenia after liver transplantation. Transplant Proc 1988;20: 630-3.
21. 21 McCaughan GW, Herkes R, Powers B, et al. Thrombocytopenia post liver transplantation: correlations with preoperative platelet count, blood transfusion requirements. allograft function and outcome. J Hepatol 1992;16:16-22.
22. 22 Levin J. Thrombopoietin-clinically realized? N Engl J Med 1997:336:434-6.
23. 23 Grossmann A, Lenox J, Ren HP, et al. Thrombopoietin accelerates platelet, red blood cells, and neutrophil recovery in myelosuppressed mice. Exp Hematol 1996;24: 1238-46.
24. 24 Meng YG, Martin TG, Peterson ML, et al. Circulating thrombopoietin concentrations in thrombocytopenic patients including cancer patients following chemotherapy with or without peripheral blood progenitor cell transplantation. Br J Haematol 1996;95:535-41.
25. 25 Porte RJ, Blauw E, Knot EAR, et al. Role of the donor liver in the origin of platelet disorders and hyperfibrinolysis in liver transplantation. J Hepatol 1994;21:592-600.
26. 26 Peck-Radosavljevic M, Wichlas M, Tai Nin C, et al. Thrombopoietin deficiency, DIC, thrombocyte consumption, and thrombocytopenia in cirrhosis [abstract]. J Hepatol 1998: 28(suppl 1):77.
27. 27 Richards EM, Alexander GJM, Nichol JL, et al. Serum thrombopoietin levels following orthotopic liver transplantation [letter]. Thromb Haemost 1997;78:1420-1.